Notice of Clarification of Application Submission Information for NOT-OD-19-071 "Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project

Notice Number: NOT-OD-19-084

Key Dates
Release Date: February 27, 2019

Related Announcements
NOT-OD-19-071

Issued by
National Institutes of Health (NIH)

Purpose

The purpose of this notice is to clarify that in an exception to standard practice, NIH will accept applications in response to NOT-OD-19-071 "Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional)" with certain specific guidelines.

Submitting an Application

Currently reads:

For R01 competitive revision supplements submitted in response to this notice, please submit all applications by March 7, not the standard due date referenced in the FOA.

In order to ensure identification, tracking, and appropriate review of their applications, all applicants MUST follow these special instructions:

Applicants should begin the Introduction to the Revision Application section by stating: This application is being submitted in response to NOT-OD-19- MMM ".

Applicants MUST insert the unique identifier "INCLUDE19-" in the beginning of the Project Title of their application. [Note: NIH limits the Project Title to 200 characters (including spaces and punctuation)].

In addition, applications should enter the following in Box 4b of the application package:"INCLUDE19"

See Frequently Asked Questions (FAQs) listed on the INCLUDE website for information about specific scientific priorities and program contacts at the NIH participating ICs (https://www.nih.gov/include-project).

Modified to read (new text is italicized):

In an exception to standard practice,for all competitive revision supplements submitted in response to this Notice, please submit all applications by March 20, 2019 and not the standard due date referenced in the corresponding FOA. Receipts dates indicated in the listed FOAs do not apply to applications responding to this request for competitive revisions. Applications for this competitive revision program only will be due on March 20, 2019. No late competitive revision applications will be accepted.

For applicants with a current active U01:

In order to ensure identification, tracking, and appropriate review of their applications, all applicants MUST follow these special instructions:

Applicants should begin the Introduction to the Revision Application section by stating: This application is being submitted in response to NOT-OD-19- 071 ".

Applicants do not need to insert unique identifier in the title of their application.

Applicants must include"NOT-OD-19-071" (without quotation marks) in the Agency Routing Identifier field (Box 4B) of the SF424 R&R form. Applications without this identifier in Box 4B will not be considered for this special initiative. In addition, applicants should include a cover letter indicating that competitive revision applications are responsive to the requirements of NOT-OD-19-071 receipt dates, and not the FOA application receipt dates.

See Frequently Asked Questions (FAQs) listed on the INCLUDE website for information about specific scientific priorities and program contacts at the NIH participating ICs (https://www.nih.gov/include-project)

All other aspects of the Notice remain unchanged.

Inquiries

Please direct all inquiries to:

Anna E. Mazzucco, PhD
National Institutes of Health (NIH)
Telephone: 301-451-1220
Email:[email protected]